Is Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP) overvalued? · rev $3.37B
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP) common stock listed on US.
This page asks whether Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP) looks expensive on cached numbers — not a short thesis.
Latest reported BRKRP revenue for 2024-12-31 was $3.37B. Net income was $113.8M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. BRKRP currently screens at market cap $0.
BRKRP currently screens at market cap $0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next BRKRP 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the BRKRP stock page for the full model, not this heading.
Not investment advice.